Keros Therapeutics, Inc. (NASDAQ:KROS) institutional owners may be pleased with recent gains after 2.4% loss over the past year

Key Insights Significantly high institutional ownership implies Keros Therapeutics' stock price is sensitive to their...

Related Keywords

Jasbir Seehra ,Keros Therapeutics Inc , ,Keros Therapeutics ,Pontifax Venture Capital ,Institutional Ownership ,Institutional Investors ,